Highlights of weekly biotech stock moves

Allenex AB (SSE:ALNX) gained SEK1.03 (48%) to SEK3.19 on Thursday after saying Mexico approved XM-ONE to detect human leukocyte antigen (HLA) and non-HLA antibodies between donor and recipient in organ transplantations.

XM-ONE is an endothelial crossmatch test kit that detects anti-endothelial cell antibodies (AECA) as well as antibodies to major histocompatibility complex (MHC) class I and II HLA antigen. The test is already marketed in the U.S. and Europe...